whilst i am interested in hearing more about mets, i am certainly not nervous. Everything we know about the investigations so far is positive, everything about the funds buying in at higher and higher prices on each cap raise says the narrative out of the company is good, the market/competitor comparisons on mets are comforting, the hires they have made in this area are comforting. And the difference with CHN is that our profitability is not going to hinge on a certain recovery rate - unless we end up with a drastically different outcome than expected. Even if you assume an average met result we still prove to be exceptionally profitable based on how high grade and not deep we are.
Mets gives me no nerves. I just see it as another step in the revaluation journey - so of course i want it asap!
General discussion, page-5248
-
- There are more pages in this discussion • 4,262 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add WA1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.27 |
Change
-2.080(10.8%) |
Mkt cap ! $1.059B | |||
| Open | High | Low | Value | Volume |
| $19.60 | $19.80 | $17.00 | $8.650M | 477.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2910 | $17.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.30 | 820 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| WA1 (ASX) Chart |